Copyright
©The Author(s) 2020.
World J Gastroenterol. May 21, 2020; 26(19): 2294-2304
Published online May 21, 2020. doi: 10.3748/wjg.v26.i19.2294
Published online May 21, 2020. doi: 10.3748/wjg.v26.i19.2294
HCA subtype | Risk factors | Specific clinical features | Histologic features | IHCs |
HHCA | HNF1A germline mutations, MODY type 3, microsatellite instability | Hepatic adenomatosis | Intralesional steatosis | LFABP (absent/decreased) |
IHCA | Obesity, alcohol, glycogenosis | Inflammatory syndrome | Sinusoidal dilatation, inflammatory infiltrate | CRP, SAA |
bex3HCA | Male, liver vascular disease, androgen therapy | Frequent malignant transformation | Pseudoacinar formation, mild nuclear atypia | beta-catenin (nuclear staining), GS (diffuse and strong) |
bex7,8HCA | No specific risk factors | No specific clinical features | No specific features | GS (weak, heterogeneous) |
shHCA | Obesity | Symptomatic bleeding | Intratumoural hemorrhage | Prostaglandin D2 synthase |
UHCA | No specific risk factors | No specific clinical features | No specific features | None |
- Citation: Hahn E, Putra J. Hepatocellular adenoma in the paediatric population: Molecular classification and clinical associations. World J Gastroenterol 2020; 26(19): 2294-2304
- URL: https://www.wjgnet.com/1007-9327/full/v26/i19/2294.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i19.2294